Across TCGA patient cohorts, CD300LD RNA expression is significantly associated with the go_rna of many other GO terms, with 6,737 significant associations in total. STAD shows the largest number of these associations.

The most reproducible CD300LD-associated GO terms across cancer lineages are Peptidyl-tyrosine modification, Regulation of peptidyl-tyrosine phosphorylation, and Osteoclast differentiation. Each is linked with CD300LD in more than 16 cancer types. Because this analysis shows association rather than direction, both CD300LD-to-partner and partner-to-CD300LD results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (CD300LD→partner) and Y-score (partner→CD300LD) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
STAD	Peptidyl-tyrosine modification →	+0.044	+0.128	<.001	<.001	3	17
STAD	Regulation of peptidyl-tyrosine phosphorylation →	+0.043	+0.123	<.001	<.001	3	16
LAML	Osteoclast differentiation →	+0.052	+0.304	<.001	<.001	3	15
STAD	Regulation of myeloid cell differentiation →	+0.048	+0.136	<.001	<.001	3	14
STAD	Myeloid leukocyte differentiation →	+0.051	+0.125	<.001	<.001	3	14
STAD	Regulation of leukocyte migration →	+0.049	+0.107	<.001	<.001	3	14

Each partner links to its Q-omics profile. Showing the 6 strongest of 6,737 associations by consensus.

Exploration

CD300LD survival (RNA) · tumor vs normal (RNA) · all CD300LD data types